Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novartis -- Ignore unavailable to you. Want to Upgrade?

To: Andreas Helke who wrote (154)	1/21/1998 8:10:00 AM
From: Chuck. Edwards	Read Replies (1) \| Respond to of 296

Since the Tuesday rally in drug stocks was sparked by merger speculation, it is natural that smaller companies would go up more than larger ones, because the large companies would naturally be the "acquirers" not the "acquirees", and the acquiring company's stock usually suffers. Since Novartis is the largest drug company in the world and not an acquisition target, I would expect it to rise less than likely target Schering-Plough for example. I am amazed at the expansion in drug company multiples. Pfizer trading at over 40 times earnings! Wow! We can no longer talk about absolute values, but must perforce look at relative ones.